Purchase Order W81XWH20P0150
Award Date 9/23/20
Potential Completion Date 3/29/21
Potential Value $250K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Huntsville, AL 35806, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
48
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency (DHA) awarded a $249,938.77 Small Business Innovation Research (SBIR) Phase I contract to Genecapture, Inc., a for-profit startup company located at the Hudson Alpha Institute for Biotechnology. The contract is for the project titled "Expanding Genecapture's Rapid Portable Invasive Fungal Infection (IFI) Diagnostics for Wound Infections." Genecapture develops rapid infectious disease detection solutions using their patented CAPTURE technology, which identifies...
- Genecapture, Inc. was awarded a definitive contract valued at $1,099,956.91 by the Department of the Army Medical Command to conduct research and development under the Small Business Innovation Research (SBIR) Program Phase II. The contract supports Proposal No. H2-0647 titled "Genecapture's Fieldable Diagnostic Platform for Rapid ID and AST of Wound Pathogens." Research will be conducted in Huntsville, Alabama over a period of performance from September 2021 through January 2024 under...
- This is a $1,271,417.59 Cost Plus Fixed Fee contract awarded by the Defense Threat Reduction Agency (DTRA), a defense agency, to Genecapture, Inc., a for-profit startup company. The contract is for a Small Business Technology Transfer (STTR) Phase II effort focused on developing infectious disease diagnostics and differentiation of viral versus bacterial infections for point-of-care applications. The contract was set aside for small businesses. Genecapture specializes in rapid infectious disease...
- The Department of the Air Force Materiel Command Research Laboratory awarded a $284,827 Other Transaction Agreement to Genecapture, Inc., a for-profit small business startup, to research and develop a ruggedized and upgraded version of a commercially available pathogen detector that can be deployed in forward environments. This award is not set aside for any specific business type. Genecapture has received prior Small Business Innovation Research (SBIR) Phase II contracts from the Army,...
- This is a Small Business Technology Transfer (STTR) Phase I contract awarded by the Defense Threat Reduction Agency (DTRA) to Genecapture, Inc., a for-profit startup company. The $150,523.52 firm-fixed-price contract is for the development of infectious disease diagnostics and differentiation of viral vs. bacterial infections for point-of-care applications. Genecapture specializes in rapid pathogen detection solutions using their patented CAPTURE technology. This contract supports DTRA's efforts...
- Genecapture, Inc. was awarded a $999,752.38 definitive cost-plus-fixed-fee contract by the Defense Threat Reduction Agency to continue research and development efforts initiated under Phase I of the Small Business Innovation Research program. The contract will support the company's work to deliver infectious disease diagnostics and differentiate between viral and bacterial infections for point-of-care applications, advancing the agency's goals of protecting the United States from weapons of mass...
- The Defense Threat Reduction Agency (DTRA) awarded Genecapture, Inc. a $4.54 million Phase III Small Business Technology Transfer (STTR) contract on November 3, 2023, to develop infectious disease diagnostics capable of differentiating viral versus bacterial infections for point-of-care applications. This definitive contract, structured as Cost Plus Fixed Fee pricing, will be performed in Huntsville, Alabama, with an ultimate completion date of July 31, 2026. The contract carries no small...
- This federal contract award, valued at $85,340.00, was issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA) on behalf of the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) to Genedata (USA), Inc., a foreign-owned, self-certified small disadvantaged business. The contract provides for the software license, maintenance, and support of Genedata Screener, the company's proprietary bioinformatics software platform, to support critical research initiatives,...
- This is a Phase II Small Business Innovation Research (SBIR) award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Chromologic LLC, a minority-owned small business headquartered in Monrovia, California. The award, valued at $1,499,763.00, is for the development of a CRISPR-based assay for portable tropical infection diagnosis (CAPTIN-D). This is a Firm Fixed Price definitive contract with a completion date of September 14, 2028. The award is...
- This is a firm fixed-price STTR Phase I contract awarded by the Medical Command (MEDCOM) of the U.S. Army to Giner Inc., a Boston-based research and development firm, for the project "RAPID AND REPROGRAMMABLE ASSAY FOR MULTIPLEXED GENE DETECTION". The contract, with a ceiling value of $166,430.81, was awarded on April 12, 2020 and has a completion date of February 11, 2022. The contract is set aside for small businesses. Giner Inc. is a Subchapter S Corporation that has extensive...